Although ASAH2 may improve insulin sensitivity and hepatic steatosis and inhibits TNF-α-induced vascular inflammation, only a few studies have targeted the manipulation of ASAH2 expression as a therapeutic approach, as ASAH2 distribution and its functions remain unclear in many respects. Here, ASAH2 is linked to fatty liver disease.